echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Review of Qilu Pharmaceutical Granisetron Hydrochloride Injection

    Review of Qilu Pharmaceutical Granisetron Hydrochloride Injection

    • Last Update: 2021-05-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 26, the NMPA official website updated the drug approval document information, and Qilu Pharmaceutical's Granisetron Hydrochloride Injection was the first to pass the consistency evaluation.


    Figure 1: Qilu Pharmaceutical's over-rated product information

    Source: NMPA official website

    Granisetron is a highly selective 5-HT3 receptor antagonist, suitable for the prevention and treatment of nausea and vomiting caused by tumor radiotherapy and chemotherapy.


    Table 1: Antiemetics and anti-nausea drugs that have been reviewed/deemed to have been reviewed earlier

    Source: Meinenet MED2.


    Note: *is the first company to pass the evaluation

    According to data from Minei.


    Table 2: 2020H1 Qilu's ranking of antiemetics and antinausea brands

    Source: Mi Nei.


    According to the comprehensive database of the MID Drug Index of Meinenet, Qilu has 7 products related to antiemetics and anti-nausea drugs, 4 of which have entered the TOP20 brand list of terminal antiemetics and anti-nausea drugs in China's public medical institutions in the first half of 2020.


    Source: Mi Nei.


    The review data statistics are as of April 26, if there are any errors or omissions, please correct me.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.